Weight, Lipids, Glucose, and Behavioral Measures With Ziprasidone Treatment in a Population With Mental Retardation - Concepedia

Concepedia

Publication | Closed Access

Weight, Lipids, Glucose, and Behavioral Measures With Ziprasidone Treatment in a Population With Mental Retardation

40

Citations

0

References

2003

Year

Seth A. Cohen, Brian Fitzgerald, Anthony Okos, Shirin Khan, Arif O. Khan

The Journal of Clinical Psychiatry

Abstract

Ziprasidone effectively reduces the frequency of maladaptive behavior in a patient group with mental retardation without causing weight gain or metabolic disturbances.